1
|
Ohene-Adjei M, Begley SL, Temes R, Schulder M. Efficacy of continuous electroencephalogram for the management of altered mental status in the neurosurgical intensive care unit. Surg Neurol Int 2023; 14:235. [PMID: 37560585 PMCID: PMC10408650 DOI: 10.25259/sni_409_2023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 06/21/2023] [Indexed: 08/11/2023] Open
Abstract
BACKGROUND Continuous electroencephalograms (cEEGs) are often used in the neurosurgical intensive care unit (NSICU) to detect subclinical seizures (SCSs) in patients with altered mental status (AMS). This retrospective study evaluated the efficacy of this approach for improving patient outcomes. METHODS We reviewed the records of 100 patients admitted to the NSICU between 2015 and 2020 who underwent continous electroencephalograms (cEEG) during workup of unexplained AMS. Patient outcomes were classified as positive (discharged), neutral (transfer of care), or negative (dead). Incidence of SCSs on cEEG and association with patient outcomes was analyzed with Chi-square analysis and relative risk (RR). RESULTS For the 99 included patients, median age was 62 years and 43% were female. About 15.2% had a known or newly diagnosed brain tumor. Outcomes were positive in 22 patients, neutral in four, and negative in 73. SCSs were detected in 15 patients, of whom 12 died, two were discharged, and one whose care was transferred. Chi-square association between SCS and outcome (P = 0.59) and RR of death associated with SCS diagnosis (1.1) was not significant. CONCLUSION We found a lower incidence of SCSs (15.2%) than reported in the literature. In the absence of clinically evident seizures, continous cEEGs performed in the NSICU to determine the etiology of AMS did not yield an improvement in patient outcomes, and patients diagnosed and treated for SCS did not have statistically decreased risk of death. In summary, electroencephalogram monitoring for SCS is important but should not delay diagnosis and treatment of other, potentially life-threating etiologies of AMS.
Collapse
Affiliation(s)
- Michael Ohene-Adjei
- Department of Neurosurgery, Donald and Barbara Zucker School of Medicine, Hempstead, United States
- Department of Neurosurgery, North Shore University Hospital, Manhasset, United States
| | - Sabrina Leone Begley
- Department of Neurosurgery, Donald and Barbara Zucker School of Medicine, Hempstead, United States
- Department of Neurosurgery, North Shore University Hospital, Manhasset, United States
| | - Richard Temes
- Department of Neurosurgery, North Shore University Hospital, Manhasset, United States
| | - Michael Schulder
- Department of Neurosurgery, North Shore University Hospital, Manhasset, United States
| |
Collapse
|
2
|
Aboul-Nour H, Jumah A, Abdulla H, Sharma A, Howell B, Jayaprakash N, Gardner-Gray J. Neurological monitoring in ECMO patients: current state of practice, challenges and lessons. Acta Neurol Belg 2023; 123:341-350. [PMID: 36701079 PMCID: PMC9878494 DOI: 10.1007/s13760-023-02193-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2022] [Accepted: 01/16/2023] [Indexed: 01/27/2023]
Abstract
BACKGROUND Extracorporeal membrane oxygenation (ECMO) in critically ill patients serves as a management option for end-stage cardiorespiratory failure in medical and surgical conditions. Patients on ECMO are at a high risk of neurologic adverse events including intracranial hemorrhage (ICH), acute ischemic stroke (AIS), seizures, diffuse cerebral edema, and hypoxic brain injury. Standard approaches to neurological monitoring for patients receiving ECMO support can be challenging for multiple reasons, including the severity of critical illness, deep sedation, and/or paralysis. This narrative literature review provides an overview of the current landscape for neurological monitoring in this population. METHODS A literature search using PubMed was used to aid the understanding of the landscape of published literature in the area of neurological monitoring in ECMO patients. RESULTS Review articles, cohort studies, case series, and individual reports were identified. A total of 73 varied manuscripts were summarized and included in this review which presents the challenges and strategies for performing neurological monitoring in this population. CONCLUSION Neurological monitoring in ECMO is an area of interest to many clinicians, however, the literature is limited, heterogenous, and lacks consensus on the best monitoring practices. The evidence for optimal neurological monitoring that could impact clinical decisions and functional outcomes is lacking. Additional studies are needed to identify effective measures of neurological monitoring while on ECMO.
Collapse
Affiliation(s)
- Hassan Aboul-Nour
- grid.189967.80000 0001 0941 6502Department of Neurology, Emory University, Atlanta, GA USA ,grid.413103.40000 0001 2160 8953Department of Neurology, Henry Ford Hospital, Detroit, MI USA
| | - Ammar Jumah
- grid.413103.40000 0001 2160 8953Department of Neurology, Henry Ford Hospital, Detroit, MI USA
| | - Hafsa Abdulla
- grid.413103.40000 0001 2160 8953Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI USA
| | - Amreeta Sharma
- grid.413103.40000 0001 2160 8953Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI USA
| | - Bradley Howell
- grid.413103.40000 0001 2160 8953Department of Neurology, Henry Ford Hospital, Detroit, MI USA
| | - Namita Jayaprakash
- grid.413103.40000 0001 2160 8953Department of Emergency Medicine, Critical Care Medicine, Henry Ford Hospital, Detroit, MI USA
| | - Jayna Gardner-Gray
- grid.413103.40000 0001 2160 8953Division of Pulmonary and Critical Care Medicine, Henry Ford Hospital, Detroit, MI USA ,grid.413103.40000 0001 2160 8953Department of Emergency Medicine, Critical Care Medicine, Henry Ford Hospital, Detroit, MI USA
| |
Collapse
|
3
|
Azary S, Caravanos C, Reiner AS, Panageas KS, Dhawan V, Avila EK. Incidence of Seizure and Associated Risk Factors in Patients in the Medical Intensive Care Unit (ICU) at Memorial Sloan Kettering Cancer Center (MSK) from 2016-2017. J Intensive Care Med 2022; 37:1312-1317. [PMID: 35128987 PMCID: PMC10155194 DOI: 10.1177/08850666211066080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background: Seizures and status epilepticus are common neurologic complications in the intensive care unit (ICU) but the incidence in a cancer ICU is unknown. It is important to understand seizure risk factors in cancer patients to properly diagnose the seizure type to ensure appropriate therapy. Methods: We identified patients admitted to the medical ICU at Memorial Sloan Kettering Cancer Center (MSK) from January 2016 to December 2017 who had continuous or routine electroencephalography (EEG) and identified clinical and electrographic seizures by chart review. Results: Of the 1059 patients admitted to the ICU between 2016 and 2017, 50 patients had clinical and/or electrographic seizures (incidence of 4.7%, 95% CI: 3.4-6.0). The incidences of clinical and electrographic seizure were 4.1% and 1.1%, respectively. In a multivariable stepwise regression model, history of seizure (OR: 2.9, 95% CI: 1.1-7.8, P: .03), brain metastasis (OR: 2.5, 95% CI: 1.1-5.8, P: .03), vasopressor requirement (OR: 2.2, 95% CI: 1.0-4.9, P: .05), and age < 65 (2.4, 95% CI: 1.2-5.0, P: .02) were associated with increased risk of seizure (either clinical or electrographic). Obtaining continuous EEG instead of routine EEG increased the yield of seizure detection significantly (OR: 3.9, 95% CI: 1.3-11.1, P: .01). No chemotherapy in the past 30 days, no antibiotic use, vasopressor requirement, and having a brain tumor increased risk of electrographic seizure. Length of continuous EEG > 24 h significantly increased the chances of both clinical and electrographic seizure detection, (OR: 2.6 [95% CI: 1.2-5.7] and 15.0 [95% CI: 2.7-82.5], respectively). Conclusions: We identified known and cancer-related risk factors which can aid clinicians in diagnosing seizures in cancer ICUs. Long-term video EEG monitoring should be considered, particularly given the treatable and reversible nature of seizures.
Collapse
Affiliation(s)
- Saeedeh Azary
- 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | - Anne S Reiner
- 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | - Vikram Dhawan
- 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - Edward K Avila
- 5803Memorial Sloan Kettering Cancer Center, New York, NY, USA
| |
Collapse
|
4
|
Chiu WT, Campozano V, Schiefecker A, Rodriguez DR, Ferreira D, Headlee A, Zeidan S, Grinea A, Huang YH, Doyle K, Shen Q, Gómez D, Hocker SE, Rohaut B, Sonneville R, Hong CT, Demeret S, Kurtz P, Maldonado N, Helbok R, Fernandez T, Claassen J. Management of Refractory Status Epilepticus: An International Cohort Study (MORSE CODe) Analysis of Patients Managed in the ICU. Neurology 2022; 99:e1191-e1201. [PMID: 35918156 PMCID: PMC9536742 DOI: 10.1212/wnl.0000000000200818] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Accepted: 04/19/2022] [Indexed: 11/15/2022] Open
Abstract
BACKGROUND AND OBJECTIVES Status epilepticus that continues after the initial benzodiazepine and a second anticonvulsant medication is known as refractory status epilepticus (RSE). Management is highly variable because adequately powered clinical trials are missing. We aimed to determine whether propofol and midazolam were equally effective in controlling RSE in the intensive care unit, focusing on management in resource-limited settings. METHODS Patients with RSE treated with midazolam or propofol between January 2015 and December 2018 were retrospectively identified among 9 centers across 4 continents from upper-middle-income economies in Latin America and high-income economies in North America, Europe, and Asia. Demographics, Status Epilepticus Severity Score, etiology, treatment details, and discharge modified Rankin Scale (mRS) were collected. The primary outcome measure was good functional outcome defined as a mRS score of 0-2 at hospital discharge. RESULTS Three hundred eighty-seven episodes of RSE (386 patients) were included, with 162 (42%) from upper-middle-income and 225 (58%) from high-income economies. Three hundred six (79%) had acute and 79 (21%) remote etiologies. Initial RSE management included midazolam in 266 (69%) and propofol in 121 episodes (31%). Seventy episodes (26%) that were initially treated with midazolam and 42 (35%) with propofol required the addition of a second anesthetic to treat RSE. Baseline characteristics and outcomes of patients treated with midazolam or propofol were similar. Breakthrough (odds ratio [OR] 1.6, 95% CI 1.3-2.0) and withdrawal seizures (OR 2.0, 95% CI 1.7-2.5) were associated with an increased number of days requiring continuous intravenous anticonvulsant medications (cIV-ACMs). Prolonged EEG monitoring was associated with fewer days of cIV-ACMs (1-24 hours OR 0.5, 95% CI 0.2-0.9, and >24 hours OR 0.7, 95% CI 0.5-1.0; reference EEG <1 hour). This association was seen in both, high-income and upper-middle-income economies, but was particularly prominent in high-income countries. One hundred ten patients (28%) were dead, and 80 (21%) had good functional outcomes at hospital discharge. DISCUSSION Outcomes of patients with RSE managed in the intensive care unit with propofol or midazolam infusions are comparable. Prolonged EEG monitoring may allow physicians to decrease the duration of anesthetic infusions safely, but this will depend on the implementation of RSE management protocols. Goal-directed management approaches including EEG targets may hold promise for patients with RSE. CLASSIFICATION OF EVIDENCE This study provides Class III data that propofol and midazolam are equivalently efficacious for RSE.
Collapse
Affiliation(s)
- Wei-Ting Chiu
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Vanessa Campozano
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Alois Schiefecker
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Dannys Rivero Rodriguez
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Daniel Ferreira
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Amy Headlee
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Sinead Zeidan
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Alexandra Grinea
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Yao-Hsien Huang
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Kevin Doyle
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Qi Shen
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Diana Gómez
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Sara E Hocker
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Benjamin Rohaut
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Romain Sonneville
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Chien-Tai Hong
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Sophie Demeret
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Pedro Kurtz
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Nelson Maldonado
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Raimund Helbok
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Telmo Fernandez
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France
| | - Jan Claassen
- From the Neurological Institute (W.-T.C., K.D., Q.S., J.C.), Columbia University, NY Presbyterian Hospital; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), Taipei Medical University; Department of Neurology (W.-T.C., Y.-H.H., C.-T.H.), School of Medicine, College of Medicine, Taipei Medical University; Taiwan; Universidad de Especialidades Espíritu Santo/Hospital Luis Vernaza (V.C., D.G., T.F.), Guayaquil, Ecuador; Department of Neurology (A.S., R.H.), Neurocritical Care, Medical University of Innsbruck, Austria; Department of Neurology (D.R.R., N.M.), Universidad San Francisco de Quito USFQ, Hospital Eugenio Espejo, Ecuador; Instituto Estadual do Cérebro Paulo Niemeyer (D.F., P.K.), Rio de Jairo; Hospital Copa Star (D.F., P.K.), Rio de Janeiro, Brazil; Division of Critical Care Neurology (A.H., S.E.H.), Department of Neurology, Mayo Clinic, Rochester, MN; Neurointensive Care Unit (S.Z., B.R., S.D.), DMU Neurosciences, AP-HP Hôpital de La Pitié Salpêtrière, Paris; Université de Paris (A.G., R.S.), INSERM UMR1148 and Department of Intensive Care Medicine, Bichat-Claude Bernard University Hospital; and Sorbonne Université (B.R.), Institut du Cerveau (ICM)-Paris Brain Institute, Inserm, CNRS, France.
| |
Collapse
|
5
|
Chen H, Atallah E, Pauldurai J, Becker A, Koubeissi M. Continuous Electroencephalogram Evaluation of Paroxysmal Events in Critically Ill Patients: Diagnostic Yield and Impact on Clinical Decision Making. Neurocrit Care 2022; 37:697-704. [PMID: 35764859 DOI: 10.1007/s12028-022-01542-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 05/31/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND Continuous electroencephalogram (cEEG) monitoring has been widely used in the intensive care unit (ICU) for the evaluation of patients in the ICU with altered consciousness to detect nonconvulsive seizures. We investigated the yield of cEEG when used to evaluate paroxysmal events in patients in the ICU and assessed the predictors of a diagnostic findings. The clinical impact of cEEG was also evaluated in this study. METHODS We identified patients in the ICU who underwent cEEG monitoring (> 6 h) to evaluate paroxysmal events between January 1, 2018, and December 31, 2019. We extracted patient demographics, medical history, neurological examination, brain imaging results, and the description of the paroxysmal events that necessitated the monitoring. We dichotomized the cEEG studies into those that captured habitual nonepileptic events or revealed epileptiform discharges (ictal or interictal), i.e., those considered to be of positive diagnostic yield (Y +), and those studies that did not show those findings (negative diagnostic yield, Y -). We also assessed the clinical impact of cEEG by documenting changes in administered antiseizure medication (ASM) before and after the cEEG. RESULTS We identified 159 recordings that were obtained for the indication of paroxysmal events, of which abnormal movements constituted the majority (n = 123). For the remaining events (n = 36), descriptions included gaze deviations, speech changes, and sensory changes. Twenty-nine percent (46 of 159) of the recordings were Y + , including the presence of ictal or interictal epileptiform discharges (n = 33), and captured habitual nonepileptic events (n = 13). A history of epilepsy was the only predictor of the study outcome. Detection of abnormal findings occurred within 6 h of the recording in most patients (30 of 46, 65%). Overall, cEEG studies led to 49 (31%) changes in ASM administration. The changes included dosage increases or initiation of ASM in patients with epileptiform discharges (n = 28) and reduction or elimination of ASM in patients with either habitual nonepileptic events (n = 5) or Y - cEEG studies (n = 16). CONCLUSIONS Continuous electroencephalogram monitoring is valuable in evaluating paroxysmal events, with a diagnostic yield of 29% in critically ill patients. A history of epilepsy predicts diagnostic studies. Both Y + and Y - cEEG studies may directly impact clinical decisions by leading to ASMs changes.
Collapse
Affiliation(s)
- Hai Chen
- Department of Neurology, George Washington University School of Medicine and Health Sciences, George Washington University, 2150 Pennsylvania Ave, NW, Washington, DC, 20037, USA.
| | - Eugenie Atallah
- Department of Neurology, George Washington University School of Medicine and Health Sciences, George Washington University, 2150 Pennsylvania Ave, NW, Washington, DC, 20037, USA
| | - Jennifer Pauldurai
- Department of Neurology, George Washington University School of Medicine and Health Sciences, George Washington University, 2150 Pennsylvania Ave, NW, Washington, DC, 20037, USA
| | - Andrew Becker
- Department of Neurology, George Washington University School of Medicine and Health Sciences, George Washington University, 2150 Pennsylvania Ave, NW, Washington, DC, 20037, USA
| | - Mohamad Koubeissi
- Department of Neurology, George Washington University School of Medicine and Health Sciences, George Washington University, 2150 Pennsylvania Ave, NW, Washington, DC, 20037, USA
| |
Collapse
|
6
|
Pinto LF, Oliveira JPSD, Midon AM. Status epilepticus: review on diagnosis, monitoring and treatment. ARQUIVOS DE NEURO-PSIQUIATRIA 2022; 80:193-203. [PMID: 35976303 PMCID: PMC9491413 DOI: 10.1590/0004-282x-anp-2022-s113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Accepted: 04/29/2022] [Indexed: 06/15/2023]
Abstract
Status epilepticus (SE) is a frequent neurological emergency associated with high morbidity and mortality. According to the new ILAE 2015 definition, SE results either from the failure of the mechanisms responsible for seizure termination or initiation, leading to abnormally prolonged seizures. The definition has different time points for convulsive, focal and absence SE. Time is brain. There are changes in synaptic receptors leading to a more proconvulsant state and increased risk of brain lesion and sequelae with long duration. Management of SE must include three pillars: stop seizures, stabilize patients to avoid secondary lesions and treat underlying causes. Convulsive SE is defined after 5 minutes and is a major emergency. Benzodiazepines are the initial treatment, and should be given fast and an adequate dose. Phenytoin/fosphenytoin, levetiracetam and valproic acid are evidence choices for second line treatment. If SE persists, anesthetic drugs are probably the best option for third line treatment, despite lack of evidence. Midazolam is usually the best initial choice and barbiturates should be considered for refractory cases. Nonconvulsive status epilepticus has a similar initial approach, with benzodiazepines and second line intravenous (IV) agents, but after that, aggressiveness should be balanced considering risk of lesion due to seizures and medical complications caused by aggressive treatment. Usually, the best approach is the use of sequential IV antiepileptic drugs (oral/tube are options if IV options are not available). EEG monitoring is crucial for diagnosis of nonconvulsive SE, after initial control of convulsive SE and treatment control. Institutional protocols are advised to improve care.
Collapse
Affiliation(s)
- Lecio Figueira Pinto
- Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento de Neurologia, Grupo de Epilepsia, São Paulo SP, Brazil
| | | | - Aston Marques Midon
- Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Departamento de Neurologia, São Paulo SP, Brazil
| |
Collapse
|
7
|
Fahy BG, Lampotang S, Cibula JE, Johnson WT, Cooper LA, Lizdas D, Gravenstein N, Vasilopoulos T. Impact of Simulation on Critical Care Fellows’ Electroencephalography Learning. Cureus 2022; 14:e24439. [PMID: 35637804 PMCID: PMC9128666 DOI: 10.7759/cureus.24439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/24/2022] [Indexed: 11/26/2022] Open
Abstract
Introduction Continuous electroencephalography (EEG) is an important monitoring modality in the intensive care unit and a key skill for critical care fellows (CCFs) to learn. Our objective was to evaluate with CCFs an EEG educational curriculum on a web-based simulator. Methods This prospective cohort study was conducted at a major academic medical center in Florida. After Institutional Review Board approval, 13 CCFs from anesthesiology, surgery, and pulmonary medicine consented to take an EEG curriculum. A 25-item EEG assessment was completed at baseline, after 10 EEG interpretations with a neurophysiologist, and after 10 clinically relevant EEG-based simulations providing clinical EEG interpretation hints. A 50-minute tutorial podcast was viewed after the baseline assessment. Main assessment outcomes included multiple outcomes related to web-based simulator performance: percent of hints used, percent of first words on EEG interpretation correct, and percent hint-based EEG interpretation score correct, with higher scores indicating more correct answers. Participants completed a 25-item EEG assessment before (baseline) and after the web-based simulator. Results All 13 CCFs completed the curriculum. Between scenarios, there were differences in percent of hints used (F9,108 = 11.7, p < 0.001), percent of first words correct (F9,108 = 13.6, p < 0.001), and overall percent hint-based score (F9,108 = 14.0, p < 0.001). Nonconvulsive status epilepticus had the lowest percent of hints used (15%) and the highest hint-based score (87%). Overall percent hint-based score (mean across all scenarios) was positively correlated with change in performance as the number of correct answers on the 25-item EEG assessment from before to after the web-based simulator activity (Spearman’s rho = 0.67, p = 0.023). Conclusions A self-paced EEG interpretation curriculum involving a flipped classroom and screen-based simulation each requiring less than an hour to complete significantly improved CCF scores on the EEG assessment compared to baseline.
Collapse
|
8
|
The economic burden of newly diagnosed epilepsy in Spain. Epilepsy Behav 2021; 125:108395. [PMID: 34781064 DOI: 10.1016/j.yebeh.2021.108395] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 09/17/2021] [Accepted: 10/21/2021] [Indexed: 12/24/2022]
Abstract
OBJECTIVE The aim of this study was to determine the hospital burden and economic impact of epilepsy in adults in Spain and identify characteristics associated with higher direct medical costs. METHOD Patients newly diagnosed with epilepsy at the outpatient epilepsy unit of a tertiary hospital in Spain in 2012 were included. Sociodemographic and clinical data and use of health resources were collected retrospectively from electronic medical records from the time of diagnosis to the end of follow-up (2019). Direct costs (in 2012 Euro) were estimated and linear regression models built to explore predictors of higher costs. RESULTS We studied 110 patients with newly diagnosed epilepsy. Their mean (SD) age was 52.6 (19.6) years and 53.6% were men. Eighty-nine patients (80.9%) had focal epilepsy and 45 (40.9%) had an unknown etiology. At 6 months, 79.1% of patients were classified as responders and 17.6% as having drug-resistant epilepsy. The mean direct cost in the first year of epilepsy diagnosis was €3816.06, 49.7% of which was due to hospital admissions. The mean annual cost per patient was €2584.17, 51.4% of which was due to anti-seizure medications (ASMs). Focal epilepsy and poor response in the first 6 months of treatment predicted higher annual costs, while focal epilepsy and pre-existing comorbidities predicted higher costs in the first year. CONCLUSIONS The direct cost of newly diagnosed epilepsy in adults in our area is €2584 per patient/year. Anti-seizure medication use is the main cost driver. Focal epilepsy, comorbidities, and poor response to ASMs are independent predictors of higher costs.
Collapse
|
9
|
Rubinos C, Alkhachroum A, Der-Nigoghossian C, Claassen J. Electroencephalogram Monitoring in Critical Care. Semin Neurol 2020; 40:675-680. [PMID: 33176375 DOI: 10.1055/s-0040-1719073] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Seizures are common in critically ill patients. Electroencephalogram (EEG) is a tool that enables clinicians to provide continuous brain monitoring and to guide treatment decisions-brain telemetry. EEG monitoring has particular utility in the intensive care unit as most seizures in this setting are nonconvulsive. Despite the increased use of EEG monitoring in the critical care unit, it remains underutilized. In this review, we summarize the utility of EEG and different EEG modalities to monitor patients in the critical care setting.
Collapse
Affiliation(s)
- Clio Rubinos
- Division of Critical Care Neurology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
| | - Ayham Alkhachroum
- Department of Neurology, Miller School of Medicine, Jackson Memorial Health System, University of Miami, Miami, Florida
| | - Caroline Der-Nigoghossian
- Neurosciences Intensive Care Unit, Department of Pharmacy, New York-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York
| | - Jan Claassen
- Department of Neurology, Columbia University, New York
| |
Collapse
|
10
|
Comanducci A, Boly M, Claassen J, De Lucia M, Gibson RM, Juan E, Laureys S, Naccache L, Owen AM, Rosanova M, Rossetti AO, Schnakers C, Sitt JD, Schiff ND, Massimini M. Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: review of an IFCN-endorsed expert group. Clin Neurophysiol 2020; 131:2736-2765. [PMID: 32917521 DOI: 10.1016/j.clinph.2020.07.015] [Citation(s) in RCA: 86] [Impact Index Per Article: 21.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 07/06/2020] [Accepted: 07/26/2020] [Indexed: 12/13/2022]
Abstract
The analysis of spontaneous EEG activity and evoked potentialsis a cornerstone of the instrumental evaluation of patients with disorders of consciousness (DoC). Thepast few years have witnessed an unprecedented surge in EEG-related research applied to the prediction and detection of recovery of consciousness after severe brain injury,opening up the prospect that new concepts and tools may be available at the bedside. This paper provides a comprehensive, critical overview of bothconsolidated and investigational electrophysiological techniquesfor the prognostic and diagnostic assessment of DoC.We describe conventional clinical EEG approaches, then focus on evoked and event-related potentials, and finally we analyze the potential of novel research findings. In doing so, we (i) draw a distinction between acute, prolonged and chronic phases of DoC, (ii) attempt to relate both clinical and research findings to the underlying neuronal processes and (iii) discuss technical and conceptual caveats.The primary aim of this narrative review is to bridge the gap between standard and emerging electrophysiological measures for the detection and prediction of recovery of consciousness. The ultimate scope is to provide a reference and common ground for academic researchers active in the field of neurophysiology and clinicians engaged in intensive care unit and rehabilitation.
Collapse
Affiliation(s)
- A Comanducci
- IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy
| | - M Boly
- Department of Neurology and Department of Psychiatry, University of Wisconsin, Madison, USA; Wisconsin Institute for Sleep and Consciousness, Department of Psychiatry, University of Wisconsin-Madison, Madison, USA
| | - J Claassen
- Department of Neurology, Columbia University Medical Center, New York Presbyterian Hospital, New York, NY, USA
| | - M De Lucia
- Laboratoire de Recherche en Neuroimagerie, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - R M Gibson
- The Brain and Mind Institute and the Department of Physiology and Pharmacology, Western Interdisciplinary Research Building, N6A 5B7 University of Western Ontario, London, Ontario, Canada
| | - E Juan
- Wisconsin Institute for Sleep and Consciousness, Department of Psychiatry, University of Wisconsin-Madison, Madison, USA; Amsterdam Brain and Cognition, Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands
| | - S Laureys
- Coma Science Group, Centre du Cerveau, GIGA-Consciousness, University and University Hospital of Liège, 4000 Liège, Belgium; Fondazione Europea per la Ricerca Biomedica Onlus, Milan 20063, Italy
| | - L Naccache
- Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France; Sorbonne Université, UPMC Université Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France
| | - A M Owen
- The Brain and Mind Institute and the Department of Physiology and Pharmacology, Western Interdisciplinary Research Building, N6A 5B7 University of Western Ontario, London, Ontario, Canada
| | - M Rosanova
- Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy; Fondazione Europea per la Ricerca Biomedica Onlus, Milan 20063, Italy
| | - A O Rossetti
- Neurology Service, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
| | - C Schnakers
- Research Institute, Casa Colina Hospital and Centers for Healthcare, Pomona, CA, USA
| | - J D Sitt
- Inserm U 1127, CNRS UMR 7225, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
| | - N D Schiff
- Feil Family Brain and Mind Research Institute, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA
| | - M Massimini
- IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy; Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Milan, Italy
| |
Collapse
|
11
|
Katyal N, Singh I, Narula N, Idiculla PS, Premkumar K, Beary JM, Nattanmai P, Newey CR. Continuous Electroencephalography (CEEG) in Neurological Critical Care Units (NCCU): A Review. Clin Neurol Neurosurg 2020; 198:106145. [PMID: 32823186 DOI: 10.1016/j.clineuro.2020.106145] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 07/20/2020] [Accepted: 08/07/2020] [Indexed: 12/17/2022]
Affiliation(s)
- Nakul Katyal
- University of Missouri, Department of Neurology, 5 Hospital Drive, CE 540, United States.
| | - Ishpreet Singh
- University of Missouri, Department of Neurology, 5 Hospital Drive, CE 540, United States.
| | - Naureen Narula
- Staten Island University Hospital, Department of Pulmonary- critical Care Medicine, 475 Seaview Avenue Staten Island, NY, 10305, United States.
| | - Pretty Sara Idiculla
- University of Missouri, Department of Neurology, 5 Hospital Drive, CE 540, United States.
| | - Keerthivaas Premkumar
- University of Missouri, Department of biological sciences, Columbia, MO 65211, United States.
| | - Jonathan M Beary
- A. T. Still University, Department of Neurobehavioral Sciences, Kirksville, MO, United States.
| | - Premkumar Nattanmai
- University of Missouri, Department of Neurology, 5 Hospital Drive, CE 540, United States.
| | - Christopher R Newey
- Cleveland clinic Cerebrovascular center, 9500 Euclid Avenue, Cleveland, OH 44195, United States.
| |
Collapse
|
12
|
Granum LK, Bush WW, Williams DC, Stecker MM, Weaver CE, Werre SR. Prevalence of electrographic seizure in dogs and cats undergoing electroencephalography and clinical characteristics and outcome for dogs and cats with and without electrographic seizure: 104 cases (2009-2015). J Am Vet Med Assoc 2020; 254:967-973. [PMID: 30938610 DOI: 10.2460/javma.254.8.967] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To determine the prevalence of electrographic seizure (ES) and electrographic status epilepticus (ESE) in dogs and cats that underwent electroencephalography (EEG) because of suspected seizure activity and to characterize the clinical characteristics, risk factors, and in-hospital mortality rates for dogs and cats with ES or ESE. DESIGN Retrospective case series. ANIMALS 89 dogs and 15 cats. PROCEDURES Medical records of dogs and cats that underwent EEG at a veterinary neurology service between May 2009 and April 2015 were reviewed. Electrographic seizure was defined as ictal discharges that evolved in frequency, duration, or morphology and lasted at least 10 seconds, and ESE was defined as ES that lasted ≥ 10 minutes. Patient signalment and history, physical and neurologic examination findings, diagnostic test results, and outcome were compared between patients with and without ES or ESE. RESULTS Among the 104 patients, ES and ESE were diagnosed in 21 (20%) and 12 (12%), respectively. Seventeen (81%) patients with ES had no or only subtle signs of seizure activity. The in-hospital mortality rate was 48% and 50% for patients with ES and ESE, respectively, compared with 19% for patients without ES or ESE. Risk factors for ES and ESE included young age, overt seizure activity within 8 hours before EEG, and history of cluster seizures. CONCLUSIONS AND CLINICAL REVELANCE Results indicated that ES and ESE were fairly common in dogs and cats with suspected seizure activity and affected patients often had only subtle clinical signs. Therefore, EEG is necessary to detect patients with ES and ESE.
Collapse
|
13
|
Zafar SF, Subramaniam T, Osman G, Herlopian A, Struck AF. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav 2020; 106:107037. [PMID: 32222672 DOI: 10.1016/j.yebeh.2020.107037] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 03/07/2020] [Accepted: 03/07/2020] [Indexed: 02/06/2023]
Abstract
Critical care long-term continuous electroencephalogram (cEEG) monitoring has expanded dramatically in the last several decades spurned by technological advances in EEG digitalization and several key clinical findings: 1-Seizures are relatively common in the critically ill-large recent observational studies suggest that around 20% of critically ill patients placed on cEEG have seizures. 2-The majority (~75%) of patients who have seizures have exclusively "electrographic seizures", that is, they have no overt ictal clinical signs. Along with the discovery of the unexpectedly high incidence of seizures was the high prevalence of EEG patterns that share some common features with archetypical electrographic seizures but are not uniformly considered to be "ictal". These EEG patterns include lateralized periodic discharges (LPDs) and generalized periodic discharges (GPDs)-patterns that at times exhibit ictal-like behavior and at other times behave more like an interictal finding. Dr. Hirsch and colleagues proposed a conceptual framework to describe this spectrum of patterns called the ictal-interictal continuum (IIC). In the following years, investigators began to answer some of the key pragmatic clinical concerns such as which patients are at risk of seizures and what is the optimal duration of cEEG use. At the same time, investigators have begun probing the core questions for critical care EEG-what is the underlying pathophysiology of these patterns, at what point do these patterns cause secondary brain injury, what are the optimal treatment strategies, and how do these patterns affect clinical outcomes such as neurological disability and the development of epilepsy. In this review, we cover recent advancements in both practical concerns regarding cEEG use, current treatment strategies, and review the evidence associating IIC/seizures with poor clinical outcomes.
Collapse
Affiliation(s)
- Sahar F Zafar
- Department of Neurology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States of America
| | - Thanujaa Subramaniam
- Department of Neurology, University of Wisconsin-Madison, Madison, WI, United States of America
| | - Gamaleldin Osman
- Department of Neurology, Henry Ford Hospital, Detroit, MI, United States of America
| | - Aline Herlopian
- Department of Neurology, Yale University, New Haven, CT, United States of America
| | - Aaron F Struck
- Department of Neurology, University of Wisconsin-Madison, Madison, WI, United States of America.
| |
Collapse
|
14
|
Vega-Zelaya L, Martín Abad E, Pastor J. Quantified EEG for the Characterization of Epileptic Seizures versus Periodic Activity in Critically Ill Patients. Brain Sci 2020; 10:brainsci10030158. [PMID: 32164273 PMCID: PMC7139566 DOI: 10.3390/brainsci10030158] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Revised: 02/28/2020] [Accepted: 03/06/2020] [Indexed: 12/22/2022] Open
Abstract
Epileptic seizures (ES) are frequent in critically ill patients and their detection and treatment are mandatory. However, sometimes it is quite difficult to discriminate between ES and non-epileptic bursts of periodic activity (BPA). Our aim was to characterize ES and BPA by means of quantified electroencephalography (qEEG). Records containing either ES or BPA were visually identified and divided into 1 s windows that were 10% overlapped. Differential channels were grouped by frontal, parieto-occipital and temporal lobes. For every channel and window, the power spectrum was calculated and the area for delta (0–4 Hz), theta (4–8 Hz), alpha (8–13 Hz), and beta (13–30 Hz) bands and spectral entropy (Se) were computed. Mean values of percentage changes normalized to previous basal activity and standardized mean difference (SMD) for every lobe were computed. We have observed that BPA are characterized by a selective increment of delta activity and decrease in Se along the scalp. Focal seizures (FS) always propagated and were similar to generalized seizures (GS). In both cases, although delta and theta bands increased, the faster bands (alpha and beta) showed the highest increments (more than 4 times) without modifications in Se. We have defined the numerical features of ES and BPA, which can facilitate its clinical identification.
Collapse
|
15
|
Abstract
OBJECTIVES To pool prevalence of nonconvulsive seizure, nonconvulsive status epilepticus, and epileptiform activity detected by different electroencephalography types in critically ills and to compare detection rates among them. DATA SOURCES MEDLINE (via PubMed) and SCOPUS (via Scopus) STUDY SELECTION:: Any type of study was eligible if studies were done in adult critically ill, applied any type of electroencephalography, and reported seizure rates. Case reports and case series were excluded. DATA EXTRACTION Data were extracted independently by two investigators. Separated pooling of prevalence of nonconvulsive seizure/nonconvulsive status epilepticus/epileptiform activity and odds ratio of detecting outcomes among different types of electroencephalography was performed using random-effect models. This meta-analysis followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and also adhered to the Meta-analyses Of Observational Studies in Epidemiology guidelines. Quality of evidence was assessed with the Newcastle-Ottawa Quality Assessment Scale for observational studies and Cochrane methods for randomized controlled trial studies. DATA SYNTHESIS A total of 78 (16,707 patients) and eight studies (4,894 patients) were eligible for pooling prevalence and odds ratios. For patients with mixed cause of admission, the pooled prevalence of nonconvulsive seizure, nonconvulsive status epilepticus, either nonconvulsive seizure or nonconvulsive status epilepticus detected by routine electroencephalography was 3.1%, 6.2%, and 6.3%, respectively. The corresponding prevalence detected by continuous electroencephalography monitoring was 17.9%, 9.1%, and 15.6%, respectively. In addition, the corresponding prevalence was high in post convulsive status epilepticus (33.5%, 20.2%, and 32.9%), CNS infection (23.9%, 18.1%, and 23.9%), and post cardiac arrest (20.0%, 17.3%, and 22.6%). The pooled conditional log odds ratios of nonconvulsive seizure/nonconvulsive status epilepticus detected by continuous electroencephalography versus routine electroencephalography from studies with paired data 2.57 (95% CI, 1.11-5.96) and pooled odds ratios from studies with independent data was 1.57 (95% CI, 1.00-2.47). CONCLUSIONS Prevalence of seizures detected by continuous electroencephalography was significantly higher than with routine electroencephalography. Prevalence was particularly high in post convulsive status epilepticus, CNS infection, and post cardiac arrest.
Collapse
|
16
|
Dericioglu N, Arsava EM, Topcuoglu MA. Time to Detection of the First Seizure in Patients With Nonconvulsive Status Epilepticus in the Neurological Intensive Care Unit. Clin EEG Neurosci 2020; 51:70-73. [PMID: 31533458 DOI: 10.1177/1550059419876509] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Video-EEG monitoring is often used to detect nonconvulsive status epilepticus (NCSE) in critical care patients. Short recording durations may fail to detect seizures. In this study, we investigated the time required to record the first ictal event, and whether it could be correlated with some clinical or EEG parameters. Video-EEG recordings of patients who were followed up in our neurological intensive care unit were evaluated retrospectively. The EEG recordings of patients with NCSE were reviewed to determine the timing of the first seizure occurrence. Demographic data and EEG findings were obtained from patient charts and EEG reports. Possible correlations between the presence of periodic discharges (PD), Glasgow Coma Scale (GCS) score and early seizure detection (defined as a seizure within the first hour of recording) were explored statistically. Out of 200 patients who underwent video-EEG monitoring, we identified 30 cases (15%; 18 male, 12 female; age 24-86 years; mean recording duration 99 hours) with NCSE. The first seizure was recorded within 0 to 1 hour in 22 patients (73%) and within 1 to 12 hours in 6 patients (22%). Interictal PDs were identified in 19 patients (63%). GCS score was ≤8 in 16 patients (53%). There was no correlation between early seizure detection and PDs (p=1.0) or GCS score (P = .22). In our study, >90% of the seizures were captured within 12 hours. This finding suggests that most of the NCSE cases can be identified even in centers with limited resources. The presence or absence of PDs or GCS score does not predict the timing of the first seizure.
Collapse
Affiliation(s)
- Nese Dericioglu
- Department of Adult Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - Ethem Murat Arsava
- Department of Adult Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - Mehmet Akif Topcuoglu
- Department of Adult Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey
| |
Collapse
|
17
|
Elf K, Ronne-Engström E, Semnic R, Rostami-Berglund E, Sundblom J, Zetterling M. Continuous EEG monitoring after brain tumor surgery. Acta Neurochir (Wien) 2019; 161:1835-1843. [PMID: 31278599 PMCID: PMC6704081 DOI: 10.1007/s00701-019-03982-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2019] [Accepted: 06/11/2019] [Indexed: 01/20/2023]
Abstract
Background Prolonged seizures generate cerebral hypoxia and increased intracranial pressure, resulting in an increased risk of neurological deterioration, increased long-term morbidity, and shorter survival. Seizures should be recognized early and treated promptly. The aim of the study was to investigate the occurrence of postoperative seizures in patients undergoing craniotomy for primary brain tumors and to determine if non-convulsive seizures could explain some of the postoperative neurological deterioration that may occur after surgery. Methods A single-center prospective study of 100 patients with suspected glioma. Participants were studied with EEG and video recording for at least 24 h after surgery. Results Seven patients (7%) displayed seizure activity on EEG recording within 24 h after surgery and another two patients (2%) developed late seizures. One of the patients with early seizures also developed late seizures. In five patients (5%), there were non-convulsive seizures. Four of these patients had a combination of clinically overt and non-convulsive seizures and in one patient, all seizures were non-convulsive. The non-convulsive seizures accounted for the majority of total seizure time in those patients. Non-convulsive seizures could not explain six cases of unexpected postoperative neurological deterioration. Postoperative ischemic lesions were more common in patients with early postoperative seizures. Conclusions Early seizures, including non-convulsive, occurred in 7% of our patients. Within this group, non-convulsive seizure activity had longer durations than clinically overt seizures, but only 1% of patients had exclusively non-convulsive seizures. Seizures were not associated with unexpected neurological deterioration. Electronic supplementary material The online version of this article (10.1007/s00701-019-03982-6) contains supplementary material, which is available to authorized users.
Collapse
|
18
|
Strein M, Holton-Burke JP, Smith LR, Brophy GM. Prevention, Treatment, and Monitoring of Seizures in the Intensive Care Unit. J Clin Med 2019; 8:E1177. [PMID: 31394791 PMCID: PMC6722541 DOI: 10.3390/jcm8081177] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 07/30/2019] [Accepted: 08/01/2019] [Indexed: 12/25/2022] Open
Abstract
The diagnosis and management of seizures in the critically ill patient can sometimes present a unique challenge for practitioners due to lack of exposure and complex patient comorbidities. The reported incidence varies between 8% and 34% of critically ill patients, with many patients often showing no overt clinical signs of seizures. Outcomes in patients with unidentified seizure activity tend to be poor, and mortality significantly increases in those who have seizure activity longer than 30 min. Prompt diagnosis and provision of medical therapy are crucial in order to attain successful seizure termination and prevent poor outcomes. In this article, we review the epidemiology and pathophysiology of seizures in the critically ill, various seizure monitoring modalities, and recommended medical therapy.
Collapse
Affiliation(s)
- Micheal Strein
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA 23298-0533, USA
| | - John P Holton-Burke
- Department of Neurology, Virginia Commonwealth University Health System, Richmond, VA 23298-0599, USA
| | - LaTangela R Smith
- Department of Neurology, Virginia Commonwealth University Health System, Richmond, VA 23298-0599, USA
| | - Gretchen M Brophy
- Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA 23298-0533, USA.
| |
Collapse
|
19
|
Elkin K, Khan U, Hussain M, Ding Y. Developments in hybrid operating room, neurointensive care unit, and ward composition and organization for stroke management. Brain Circ 2019; 5:84-89. [PMID: 31334361 PMCID: PMC6611190 DOI: 10.4103/bc.bc_11_19] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2019] [Revised: 06/02/2019] [Accepted: 06/03/2019] [Indexed: 01/19/2023] Open
Abstract
Stroke is the leading cause of adult disability in the US. Rapid diagnosis and treatment of stroke, in addition to efficacious rehabilitation, is invaluable. The present review aims to report the recent improvements in hybrid operating rooms (hybrid ORs), and in the organization of Neurological intensive care unit (NICUs) and dedicated stroke wards (SWs), which contribute to enhanced stroke treatment. A PubMed literature review was conducted in addition to the collection of other online media releases regarding recent organizational advances in stroke care. PubMed keywords included but were not limited to “neurological intensive care unit,” “hybrid operating room,” and “stroke ward,” while all other online information regarding recent advances in the physical organization was selected and synthesized in accord with its relevance. The current research indicates that hybrid ORs facilitate surgical innovation and improved patient care through the colocation of advanced imaging modalities and surgical capabilities. Moreover, the recent reorganization of NICUs and SWs may lead to better-quality initial treatment and rehabilitation. The present review also considers the current ER triage protocol for stroke patients, and it concludes with relevant considerations relating to the role of the physical hospital structure and organization in stroke care.
Collapse
Affiliation(s)
- Kenneth Elkin
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA
| | - Usama Khan
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA
| | - Mohammed Hussain
- Department of Neurology, University of Connecticut, Farmington, CT, USA
| | - Yuchuan Ding
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA.,Department of Research and Development Center, John D. Dingell VA Medical Center, Detroit, Michigan, USA
| |
Collapse
|
20
|
Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke. Curr Neurol Neurosci Rep 2019; 19:37. [PMID: 31134438 DOI: 10.1007/s11910-019-0957-4] [Citation(s) in RCA: 67] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
PURPOSE OF REVIEW In this review, we summarize the recent literature regarding the incidence and treatment of seizures arising after ischemic and hemorrhagic strokes. Additionally, we identify open questions in guidelines and standard clinical care to aid future studies aiming to improve management of seizures in post-stroke patients. RECENT FINDINGS Studies demonstrate an increasing prevalence of seizures following strokes, probably a consequence of advances in post-stroke management and expanding use of continuous EEG monitoring. Post-stroke seizures are associated with longer hospitalization and increased mortality; therefore, prevention and timely treatment of seizures are important. The standard of care is to treat recurrent seizures with anti-epileptic drugs (AEDs) regardless of the etiology. However, there are no established guidelines currently for prophylactic use of AEDs following a stroke. The prevalence of post-stroke seizures is increasing. Further studies are needed to determine the risk factors for recurrent seizures and epilepsy after strokes and optimal treatment strategies.
Collapse
|
21
|
Grönheit W, Popkirov S, Wehner T, Schlegel U, Wellmer J. Practical Management of Epileptic Seizures and Status Epilepticus in Adult Palliative Care Patients. Front Neurol 2018; 9:595. [PMID: 30116217 PMCID: PMC6082965 DOI: 10.3389/fneur.2018.00595] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2018] [Accepted: 07/04/2018] [Indexed: 11/13/2022] Open
Abstract
In terminally ill patients, paroxysmal or episodic changes of consciousness, movements and behavior are frequent. Due to ambiguous appearance, the correct diagnosis of epileptic seizures (ES) and non-epileptic events (NEE) is often difficult. Treatment is frequently complicated by the underlying condition, and an approach indicated in healthier patients may not always be appropriate in the palliative care setting. This article provides recommendations for diagnosis of ES and NEE and treatment options for ES in adult palliative care patients, including aspects of alternative administration routes for antiepileptic drugs such as intranasal, subcutaneous, or rectal application.
Collapse
Affiliation(s)
- Wenke Grönheit
- Ruhr-Epileptology, Department of Neurology, University Hospital Bochum, Bochum, Germany.,Department of Neurology, University Hospital Bochum, Bochum, Germany
| | - Stoyan Popkirov
- Department of Neurology, University Hospital Bochum, Bochum, Germany
| | - Tim Wehner
- Ruhr-Epileptology, Department of Neurology, University Hospital Bochum, Bochum, Germany.,Department of Neurology, University Hospital Bochum, Bochum, Germany
| | - Uwe Schlegel
- Department of Neurology, University Hospital Bochum, Bochum, Germany
| | - Jörg Wellmer
- Ruhr-Epileptology, Department of Neurology, University Hospital Bochum, Bochum, Germany.,Department of Neurology, University Hospital Bochum, Bochum, Germany
| |
Collapse
|
22
|
Freund B, Probasco JC, Ritzl EK. Seizure incidence in the acute postneurosurgical period diagnosed using continuous electroencephalography. J Neurosurg 2018:1-7. [PMID: 30067470 DOI: 10.3171/2018.1.jns171466] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Accepted: 01/10/2018] [Indexed: 11/06/2022]
Abstract
OBJECTIVEDelay in diagnosis and subsequent treatment of nonconvulsive seizures can lead to worsened outcomes. The gold standard in detecting nonconvulsive seizures is continuous video-electroencephalography (cEEG). Compared to routine, 30-minute EEG, the use of cEEG increases the likelihood of capturing intermittent nonconvulsive seizures. Studies of critically ill patients in intensive care units demonstrate a particularly high rate of nonconvulsive seizures. Some of these studies included postneurosurgical patients, but often subanalyses of specific populations were not done. In particular, few studies have specifically evaluated postneurosurgical patients by using cEEG in the acute postoperative setting. Therefore, the incidence and predictors of acute postneurosurgical seizures are unclear.METHODSIn this study, the authors focused on patients who were admitted to the neurological critical care unit following neurosurgery and who underwent cEEG monitoring within 72 hours of surgery.RESULTSA total of 105 cEEG studies were performed in 102 patients. Twenty-nine patients demonstrated electrographic (subclinical) seizures, of whom 10 had clinical seizures clearly documented either before or during cEEG monitoring. Twenty-two patients had subclinical seizures only detected on cEEG, 19 of whom did not have clinical seizure activity at any point during hospitalization. Those with seizures were more likely to have had a history of epilepsy (p = 0.006). The EEG studies of patients with seizures were more likely to show lateralized periodic discharges (p = 0.012) and lateralized rhythmic delta activity (p = 0.012). The underlying neuropathological disorders most associated with seizure risk were lobar tumor on presentation (p = 0.048), subdural hematoma (SDH) requiring craniotomy for evacuation (p = 0.002), subarachnoid hemorrhage (SAH) (p = 0.026), and perioperative SAH (p = 0.019). In those undergoing craniotomy, the presence of SDH (p = 0.032), particularly if requiring evacuation (p = 0.003), increased the risk of seizures. In those without preoperative intracranial bleeding, perioperative SAH after craniotomy was associated with a higher incidence of seizures (p = 0.014). There was an additive effect on seizure incidence when perioperative SAH as well as concomitant intraparenchymal hemorrhage and/or stroke were present. The clinical examination of the patient, including the presence or absence of altered mental status and the presence or absence of repetitive movements, was not predictive of subclinical seizures.CONCLUSIONSIn postneurosurgical patients referred for cEEG monitoring, there is a high rate of both clinical and subclinical seizures in the early postoperative period. Seizures are particularly common in patients with SDH or lobar tumor and perioperative SAH. There was an additive effect on seizure incidence when more extensive brain injury was present. As expected, those with a history of epilepsy also demonstrated higher seizure rates. Further studies are needed to evaluate the time period of maximum seizure incidence after surgery, and the effects acute postneurosurgical seizures have on long-term outcomes.
Collapse
|
23
|
Mesraoua B, Deleu D, Al Hail H, Ibrahim F, Melikyan G, Al Hussein H, Singh R, Uthman B, Streletz L, Kaplan PW, Wieser HG. Clinical presentation, epidemiology, neurophysiological findings, treatment and outcome of nonconvulsive status epilepticus: a 3-year prospective, hospital-based study. J Drug Assess 2017; 6:18-32. [PMID: 29201532 PMCID: PMC5700530 DOI: 10.1080/21556660.2017.1396992] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2017] [Revised: 09/20/2017] [Accepted: 10/16/2017] [Indexed: 12/02/2022] Open
Abstract
Objective: This study reports the prevalence of Nonconvulsive Status Epilepticus (NCSE) in patients with altered mental status (AMS), and describes the clinical presentation, etiology, neurophysiological findings, neuroimaging, treatment, and outcome of NCSE in Qatar. Recording duration of continuous EEG monitoring was also discussed. Methods: This was a 3-year, prospective, hospital-based study involving patients with AMS and continuous EEG monitoring admitted to the Emergency and ICUs of Hamad Hospital, Qatar. Patients with confirmed diagnosis of NCSE were compared to the patients who did not show EEG and clinical features compatible with NCSE. Descriptive statistics in terms of mean with standard deviation, as well as frequency and percentages for categorical variables, were calculated; Student’s t test as well as Chi-square tests or Fisher’s exact tests were applied. Logistic regressions NSCE was performed using significance level 0.05 for independent variables at univariate analysis. Results: Number of patients with AMS and continuous EEG monitoring was 250. Number of patients with EEG compatible with NCSE: 65 (age range, 12–79 ys; m, 37; f, 28). Number of controls (defined as patients with EEG not compatible with NCSE): 185 (age range, 12–80 ys; m, 101; f, 84). Rate of occurrence of NCSE in patients with AMS: 26%. NCSE group was younger than controls (p < .001). Twenty patients with NCSE (31%) and 35 patients in the control group (19%) died. Death was more frequent in comatose NCSE compared to controls (p < .0007). NCSE proper and comatose NCSE had longer hospital stays than controls (p < .02 and p < .03, respectively). Complete recovery occurred in 26 NCSE patients (40%) and in 98 controls (53%) (p < .08). Twenty-one patients (31%) presented with refractory NCSE: 12 patients survived, 9 died. Conclusion: This was the first prospective study reporting a high number of NCSE in Qatar, a small country in the MENA region. This prevalence (26%) was in the middle range. NCSE patients did not perform better than controls, outcome being worse with comatose NCSE. NCSE is an emergent condition warranting expedited diagnosis and management. Three days of continuous EEG monitoring were able to diagnose most cases of NCSE.
Collapse
Affiliation(s)
| | - Dirk Deleu
- Hamad Medical CorporationDohaQatar.,Weill Cornell Medical CollegeDohaQatar
| | - Hassan Al Hail
- Hamad Medical CorporationDohaQatar.,Weill Cornell Medical CollegeDohaQatar
| | | | - Gayane Melikyan
- Hamad Medical CorporationDohaQatar.,Weill Cornell Medical CollegeDohaQatar
| | | | | | | | | | | | | |
Collapse
|
24
|
Kim CS. Analysis of the Continuous Monitored Electroencephalogram Patterns in Intensive Care Unit. KOREAN JOURNAL OF CLINICAL LABORATORY SCIENCE 2017. [DOI: 10.15324/kjcls.2017.49.3.294] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- Cheon-Sik Kim
- Departments of Neurology, Asan Medical Center, 05505, Seoul, Korea
| |
Collapse
|
25
|
Bentes C, Martins H, Peralta AR, Casimiro C, Morgado C, Franco AC, Fonseca AC, Geraldes R, Canhão P, Pinho e Melo T, Paiva T, Ferro JM. Post-stroke seizures are clinically underestimated. J Neurol 2017; 264:1978-1985. [DOI: 10.1007/s00415-017-8586-9] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2017] [Revised: 07/29/2017] [Accepted: 07/31/2017] [Indexed: 10/19/2022]
|
26
|
Evaluation of a novel median power spectrogram for seizure detection by non-neurophysiologists. Seizure 2017; 50:109-117. [DOI: 10.1016/j.seizure.2017.06.016] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Revised: 05/09/2017] [Accepted: 06/13/2017] [Indexed: 11/20/2022] Open
|
27
|
Schmitt SE. Utility of Clinical Features for the Diagnosis of Seizures in the Intensive Care Unit. J Clin Neurophysiol 2017; 34:158-161. [PMID: 27571047 DOI: 10.1097/wnp.0000000000000335] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
PURPOSE Seizures in the intensive care unit are often subtle, and may have little or no clinical correlate. This study attempts to determine what clinical features are most strongly associated with the presence of electrographic seizures on continuous EEG (cEEG) monitoring. METHODS A retrospective review for all patients who underwent cEEG monitoring between January 2003 and March 2009 for either characterization of clinical events or altered mental status was performed. Clinical events were categorized as (1) limb myoclonus/tremor, (2) extremity weakness, (3) eye movement abnormalities, (4) facial/periorbital twitching, and (5) other abnormal movements. The presence of associated dyscognitive event features was also recorded. RESULTS Records from 626 patients who underwent cEEG were reviewed-154 for event characterization and 472 for altered mental status. Seizures were captured in 48 patients (31.2%) undergoing cEEG monitoring for characterization of clinical events. This was not significantly different from the incidence of seizures in patients undergoing cEEG for altered mental status (N = 133, 28.2%). Patients undergoing cEEG monitoring for facial/periorbital twitching were significantly more likely to have electrographic seizures (78.9%, P < 0.005) than patients undergoing cEEG for altered mental status or characterization of other types of events. CONCLUSIONS The incidence of seizures in patients in the intensive care unit with clinical events is generally not significantly higher than the incidence of seizures in patients in the intensive care unit with altered mental status. However, the presence of facial/periorbital twitching was associated a higher incidence of electrographic seizures.
Collapse
Affiliation(s)
- Sarah E Schmitt
- *PENN Epilepsy Center, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A.; and †Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, U.S.A
| |
Collapse
|
28
|
Altindağ E, Okudan ZV, Tavukçu Özkan S, Krespi Y, Baykan B. Electroencephalographic Patterns Recorded by Continuous EEG Monitoring in Patients with Change of Consciousness in the Neurological Intensive Care Unit. Noro Psikiyatr Ars 2017; 54:168-174. [PMID: 28680316 DOI: 10.5152/npa.2016.14822] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2016] [Accepted: 02/01/2016] [Indexed: 11/22/2022] Open
Abstract
INTRODUCTION Our aim was to examine the frequency of various electrographic patterns including periodic discharges (PD), repetitive spike waves (RSW), rhythmic delta activities (RDA), nonconvulsive seizures (NCS) and nonconvulsive status epilepticus (NCSE) in continuous EEG monitoring (cEEG) of the critically ill patients with change of consciousness and the presence of specific clinical and laboratory findings associated with these important patterns in this study. METHODS Patients with changes of consciousness in the neurological intensive care unit (NICU) were consecutively monitored with cEEG during 2 years. Their clinical, electrophysiological, radiological and laboratory findings were evaluated retrospectively. RESULTS This sample consisted of 57 (25 men) patients with a mean age of 68.2 years. Mean duration of cEEG monitoring was 2532.6 minutes. The most common electrographic patterns were PD (33%) and NCS-NCSE (26.3%). The presence of NCS-NCSE was significantly associated with PD (57.9%, p<0.001). PD and NCS-NCSE were the mostly seen in patients with acute stroke and hypoxic encephalopathy. Duration of monitoring was significantly longer in the group with PD and NCS-NCSE (p:0.004, p:0.014). Detection of any electrographic pattern in EEG before monitoring was associated with the presence of any pattern in cEEG (59.3%, p<0.0001). Convulsive or nonconvulsive seizure during monitoring was common in patients with electrographic patterns (p<0.0001). 66.7% of NCS-NCSE was seen within the first 12 hours and 26.7% was seen within the 12-24 hours of the monitoring. CONCLUSION Detection of any electrographic pattern in EEG before monitoring was associated with the presence of any important pattern in cEEG monitoring. This association suggest that at least 24 hours-monitoring of these patients could be useful for the diagnosis of clinical and/or electrographic seizures.
Collapse
Affiliation(s)
- Ebru Altindağ
- Department of Neurology, İstanbul Florence Nightingale Hospital, İstanbul, Turkey
| | | | | | - Yakup Krespi
- Stroke Rehabilitation and Research Unit Memorial Şişli Hospital, İstanbul, Turkey
| | - Betül Baykan
- Department of Neurology, Clinical Neurophysiology Unit, İstanbul University İstanbul School of Medicine, İstanbul, Turkey
| |
Collapse
|
29
|
Continuous electroencephalographic-monitoring in the ICU: an overview of current strengths and future challenges. Curr Opin Anaesthesiol 2017; 30:192-199. [PMID: 28151826 DOI: 10.1097/aco.0000000000000443] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
PURPOSE OF REVIEW In ICUs, numerous physiological parameters are continuously monitored and displayed. Yet, functional monitoring of the organ of primary concern, the brain, is not routinely performed. Despite the benefits of ICU use of continuous electroencephalographic (EEG)-monitoring (cEEG) is increasingly recognized, several issues nevertheless seem to hamper its widespread clinical implementation. RECENT FINDINGS Utilization of ICU cEEG has significantly improved detection and characterization of cerebral pathology, prognostication and clinical management in specific patient groups. Potential solutions to several remaining challenges are currently being established. Descriptive EEG-terminology is evolving, whereas logistical issues are dealt with using telemedicine and quantitative EEG trends, training of nonexpert personnel and development of specialized detection algorithms. These concerted solutions are advancing cEEG-registration towards cEEG-monitoring. Notwithstanding these advances, obstacles such as ambiguous EEG-interpretation and differences in treatment based on EEG-findings need yet to be overcome. SUMMARY In selected critically ill patient groups, ICU cEEG has clear benefits over (repeated) standard EEG or no functional brain monitoring at all and if available, cEEG should be used. However, several issues preventing optimal ICU cEEG usage persist and should be further explored.
Collapse
|
30
|
Utilization of Quantitative EEG Trends for Critical Care Continuous EEG Monitoring: A Survey of Neurophysiologists. J Clin Neurophysiol 2017; 33:538-544. [PMID: 27922904 DOI: 10.1097/wnp.0000000000000287] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
PURPOSE Quantitative EEG (QEEG) can be used to assist with review of large amounts of data generated by critical care continuous EEG monitoring. This study aimed to identify current practices regarding the use of QEEG in critical care continuous EEG monitoring of critical care patients. METHODS An online survey was sent to 796 members of the American Clinical Neurophysiology Society (ACNS), instructing only neurophysiologists to participate. RESULTS The survey was completed by 75 neurophysiologists that use QEEG in their practice. Survey respondents reported that neurophysiologists and neurophysiology fellows are most likely to serve as QEEG readers (97% and 52%, respectively). However, 21% of respondents reported nonneurophysiologists are also involved with QEEG interpretation. The majority of nonneurophysiologist QEEG data review is aimed to alert neurophysiologists to periods of concern, but 22% reported that nonneurophysiologists use QEEG to directly guide clinical care. Quantitative EEG was used most frequently for seizure detection (92%) and burst suppression monitoring (59%). A smaller number of respondents use QEEG for monitoring the depth of sedation (29%), ischemia detection (28%), vasospasm detection (28%) and prognosis after cardiac arrest (21%). About half of the respondents do not review every page of the raw critical care continuous EEG record when using QEEG. Respondents prefer a panel of QEEG trends displayed as hemispheric data, when applicable. There is substantial variability regarding QEEG trend preferences for seizure detection and ischemia detection. CONCLUSIONS QEEG is being used by neurophysiologists and nonneurophysiologists for applications beyond seizure detection, but practice patterns vary widely. There is a need for standardization of QEEG methods and practices.
Collapse
|
31
|
Abstract
In subarachnoid hemorrhage (SAH), seizures are frequent and occur at different time points, likely reflecting heterogeneous pathophysiology. Young patients, those with more severe SAH (by clot burden or presence of severe mental status changes at onset or focal neurologic deficits at any time), those with associated increased cortical irritation (by infarction or presence of underlying hematoma), and patients undergoing craniotomy are at higher risk. Advanced neurophysiologic monitoring allows for seizure burden quantification, identification of subclinical seizures, and interictal patterns as well as neurovascular complications that may have an independent impact on the outcome in this population. Practice regarding seizure prophylaxis varies widely; its institution is often guided by the risk-benefit ratio of seizures and medication side effects. Newer anticonvulsants seem to be equally effective and may have a more favorable profile. However, questions regarding the association of seizures and vasospasm, the therapeutic dosing, timing, and duration of antiepileptic treatment and the impact of seizures and antiepileptics on the outcome remain unanswered. In this review, we provide a broad overview of the work in this area and offer a diagnostic and therapeutic approach based on our own expert opinion.
Collapse
|
32
|
Billakota S, Sinha SR. Utility of Continuous EEG Monitoring in Noncritically lll Hospitalized Patients. J Clin Neurophysiol 2016; 33:421-425. [DOI: 10.1097/wnp.0000000000000270] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
33
|
Haider HA, Esteller R, Hahn CD, Westover MB, Halford JJ, Lee JW, Shafi MM, Gaspard N, Herman ST, Gerard EE, Hirsch LJ, Ehrenberg JA, LaRoche SM. Sensitivity of quantitative EEG for seizure identification in the intensive care unit. Neurology 2016; 87:935-44. [PMID: 27466474 DOI: 10.1212/wnl.0000000000003034] [Citation(s) in RCA: 68] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2015] [Accepted: 05/19/2016] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To evaluate the sensitivity of quantitative EEG (QEEG) for electrographic seizure identification in the intensive care unit (ICU). METHODS Six-hour EEG epochs chosen from 15 patients underwent transformation into QEEG displays. Each epoch was reviewed in 3 formats: raw EEG, QEEG + raw, and QEEG-only. Epochs were also analyzed by a proprietary seizure detection algorithm. Nine neurophysiologists reviewed raw EEGs to identify seizures to serve as the gold standard. Nine other neurophysiologists with experience in QEEG evaluated the epochs in QEEG formats, with and without concomitant raw EEG. Sensitivity and false-positive rates (FPRs) for seizure identification were calculated and median review time assessed. RESULTS Mean sensitivity for seizure identification ranged from 51% to 67% for QEEG-only and 63%-68% for QEEG + raw. FPRs averaged 1/h for QEEG-only and 0.5/h for QEEG + raw. Mean sensitivity of seizure probability software was 26.2%-26.7%, with FPR of 0.07/h. Epochs with the highest sensitivities contained frequent, intermittent seizures. Lower sensitivities were seen with slow-frequency, low-amplitude seizures and epochs with rhythmic or periodic patterns. Median review times were shorter for QEEG (6 minutes) and QEEG + raw analysis (14.5 minutes) vs raw EEG (19 minutes; p = 0.00003). CONCLUSIONS A panel of QEEG trends can be used by experts to shorten EEG review time for seizure identification with reasonable sensitivity and low FPRs. The prevalence of false detections confirms that raw EEG review must be used in conjunction with QEEG. Studies are needed to identify optimal QEEG trend configurations and the utility of QEEG as a screening tool for non-EEG personnel. CLASSIFICATION OF EVIDENCE REVIEW This study provides Class II evidence that QEEG + raw interpreted by experts identifies seizures in patients in the ICU with a sensitivity of 63%-68% and FPR of 0.5 seizures per hour.
Collapse
Affiliation(s)
- Hiba A Haider
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT.
| | - Rosana Esteller
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Cecil D Hahn
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - M Brandon Westover
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Jonathan J Halford
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Jong W Lee
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Mouhsin M Shafi
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Nicolas Gaspard
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Susan T Herman
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Elizabeth E Gerard
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Lawrence J Hirsch
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Joshua A Ehrenberg
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | - Suzette M LaRoche
- From the Department of Neurology (H.A.H., J.A.E., S.M.L.), Emory University School of Medicine, Atlanta, GA; Neuropace Inc. (R.E.), Mountain View, CA; Division of Neurology (C.D.H.), The Hospital for Sick Children, and Department of Paediatrics, University of Toronto, Canada; Department of Neurology (M.B.W.), Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurology (J.J.H.), Medical University of South Carolina, Charleston; Brigham and Women's Hospital (J.W.L., M.M.S., S.T.H.), Harvard Medical School, Boston, MA; Université Libre de Bruxelles (N.G.), Brussels, Belgium; Department of Neurology (E.E.G.), Northwestern University Feinberg School of Medicine, Chicago, IL; and Yale University Hospital (L.J.H.), New Haven, CT
| | | |
Collapse
|
34
|
Abstract
This update comprises six important topics under neurocritical care that require reevaluation. For post-cardiac arrest brain injury, the evaluation of the injury and its corresponding therapy, including temperature modulation, is required. Analgosedation for target temperature management is an essential strategy to prevent shivering and minimizes endogenous stress induced by catecholamine surges. For severe traumatic brain injury, the diverse effects of therapeutic hypothermia depend on the complicated pathophysiology of the condition. Continuous electroencephalogram monitoring is an essential tool for detecting nonconvulsive status epilepticus in the intensive care unit (ICU). Neurocritical care, including advanced hemodynamic monitoring, is a fundamental approach for delayed cerebral ischemia following subarachnoid hemorrhage. We must be mindful of the high percentage of ICU patients who may develop sepsis-associated brain dysfunction.
Collapse
Affiliation(s)
- Yasuhiro Kuroda
- Department of Emergency, Disaster, and Critical Care Medicine, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki, Kita, Kagawa Japan 761-0793
| |
Collapse
|
35
|
Diagnostic Accuracy of Electrographic Seizure Detection by Neurophysiologists and Non-Neurophysiologists in the Adult ICU Using a Panel of Quantitative EEG Trends. J Clin Neurophysiol 2016; 32:324-30. [PMID: 26241242 DOI: 10.1097/wnp.0000000000000144] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
PURPOSE To evaluate the sensitivity and specificity of a panel of quantitative EEG (qEEG) trends for seizure detection in adult intensive care unit (ICU) patients when reviewed by neurophysiologists and non-neurophysiologists. METHODS One hour qEEG panels (n = 180) were collected retrospectively from 45 ICU patients and were distributed to 5 neurophysiologists, 7 EEG technologists, and 5 Neuroscience ICU nurses for evaluation of seizures. Each panel consisted of the following qEEG tools, displayed separately for left and right hemisphere electrodes: rhythmicity spectrogram (rhythmic run detection and display; Persyst Inc), color density spectral array, EEG asymmetry index, and amplitude integrated EEG. The reviewers did not have access to the raw EEG data. RESULTS For the reviewer's ability to detect the presence of seizures on qEEG panels when compared with the gold standard of independent raw EEG review, the sensitivities and specificities are as follows: neurophysiologists 0.87 and 0.61, EEG technologists 0.80 and 0.80, and Neuroscience ICU nurses 0.87 and 0.61, respectively. There was no statistical difference among the three groups regarding sensitivity. CONCLUSIONS Quantitative EEG display panels are a promising tool to aid detection of seizures by non-neurophysiologists as well as by neurophysiologists. However, even when used as a panel, qEEG trends do not appear to be adequate as the sole method for reviewing continuous EEG data.
Collapse
|
36
|
Baseline EEG pattern on continuous ICU EEG monitoring and incidence of seizures. J Clin Neurophysiol 2016; 32:147-51. [PMID: 25437330 DOI: 10.1097/wnp.0000000000000157] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
PURPOSE To identify the probability of detecting nonconvulsive seizures based on the initial pattern seen in the first 30 minutes of continuous EEG (cEEG) monitoring. METHODS Continuous EEG monitoring reports from 243 adult patients were reviewed, assessing the baseline cEEG monitoring pattern and the presence of seizures during the entire monitoring period. The baseline EEG patterns were classified into nine categories: seizures, lateralized periodic discharges, generalized periodic discharges, focal epileptiform discharges, burst suppression, asymmetric background, generalized slowing, generalized periodic discharges with triphasic morphology, and normal. RESULTS Overall, 51 patients (21%) had nonconvulsive seizures at any time during cEEG monitoring. Notably, 112 patients had generalized slowing as the initial EEG pattern, and none of these patients were noted to have seizures. Seizure rates among the types of baseline EEG findings were as follows: lateralized periodic discharges (56%, n = 9), burst suppression (50%, n = 10), generalized periodic discharges (50%, n = 2), normal (33%, n = 3), focal epileptiform discharges (31%, n = 35), and asymmetric background (11%, n = 46). CONCLUSIONS Patients with only generalized slowing seen on the baseline EEG recording are unlikely to develop seizures on subsequent cEEG monitoring. Depending on the clinical circumstance, the standard duration of cEEG recording (24-48 hours) may be unnecessary in patients with generalized slowing as their only cEEG abnormality.
Collapse
|
37
|
Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol 2016; 32:87-95. [PMID: 25626778 DOI: 10.1097/wnp.0000000000000166] [Citation(s) in RCA: 351] [Impact Index Per Article: 43.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
INTRODUCTION Critical Care Continuous EEG (CCEEG) is a common procedure to monitor brain function in patients with altered mental status in intensive care units. There is significant variability in patient populations undergoing CCEEG and in technical specifications for CCEEG performance. METHODS The Critical Care Continuous EEG Task Force of the American Clinical Neurophysiology Society developed expert consensus recommendations on the use of CCEEG in critically ill adults and children. RECOMMENDATIONS The consensus panel recommends CCEEG for diagnosis of nonconvulsive seizures, nonconvulsive status epilepticus, and other paroxysmal events, and for assessment of the efficacy of therapy for seizures and status epilepticus. The consensus panel suggests CCEEG for identification of ischemia in patients at high risk for cerebral ischemia; for assessment of level of consciousness in patients receiving intravenous sedation or pharmacologically induced coma; and for prognostication in patients after cardiac arrest. For each indication, the consensus panel describes the patient populations for which CCEEG is indicated, evidence supporting use of CCEEG, utility of video and quantitative EEG trends, suggested timing and duration of CCEEG, and suggested frequency of review and interpretation. CONCLUSION CCEEG has an important role in detection of secondary injuries such as seizures and ischemia in critically ill adults and children with altered mental status.
Collapse
|
38
|
Abstract
OPINION STATEMENT Continuous electroencephalographic (EEG) monitoring has become an invaluable tool for the assessment of brain function in critically ill patients. However, interpretation of EEG waveforms, especially in the intensive care unit (ICU) setting is fraught with ambiguity. The term ictal-interictal continuum encompasses EEG patterns that are potentially harmful and can cause neuronal injury. There are no clear guidelines on how to treat EEG patterns that lie on this continuum. We advocate the following approaches in a step wise manner: (1) identify and exclude clear electrographic seizures and status epilepticus (SE), i.e., generalized spike-wave discharges at 3/s or faster; and clearly evolving discharges of any type (rhythmic, periodic, fast activity), whether focal or generalized; (2) exclude clear interictal patterns, i.e., spike-wave discharges, periodic discharges, and rhythmic patterns at 1/s or slower with no evolution, unless accompanied by a clear clinical correlate, which would make them ictal regardless of the frequency; (3) consider any EEG patterns that lie in between the above two categories as being on the ictal-interictal continuum; (4) compare the electrographic pattern of the ictal-incterictal continuum to the normal background and unequivocal seizures (if present) from the same patient; (5) when available, correlate ictal-interictal continuum pattern with other markers of neuronal injury such as neuronal specific enolase (NSE) levels, brain imaging findings, depth electrode recordings, data from microdialysis, intracranial pressure fluctuations, and brain oxygen measurement; and (6) perform a diagnostic trial with preferably a nonsedating antiepileptic drug with the endpoint being both clinical and electrographic improvement. Minimize the use of anesthetics or multiple AEDs unless there is clear supporting evidence from ancillary tests or worsening of the EEG patterns over time, which could indicate possible neuronal injury.
Collapse
|
39
|
Poothrikovil RP, Gujjar AR, Al-Asmi A, Nandhagopal R, Jacob PC. Predictive Value of Short-Term EEG Recording in Critically ill Adult Patients. Neurodiagn J 2016; 55:157-68. [PMID: 26630808 DOI: 10.1080/21646821.2015.1068063] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
We assessed the EEG patterns and their prognostic significance in critically ill adult patients with encephalopathy, by digital EEGs lasting lip to 1 hour Of the 110 patients (age: 43.8 ± 19.4 years, male: female:1.6:1) studied, 32% had hypoxic ischemic encephalopathy (HIE), 17% severe infections, and 14.5% stroke. Observed EEG patterns were diffuse slowing (41%), low-voltage cerebral activity (LVCA, 18%), nonconvulsive status epilepticus (NCSE, 13.6%), and periodic abnormalities (9.1%). LVCA, age, Glasgow Coma Score (GCS) < 8, HIE, and modified Hockaday's EEG grades of IV and V were associated with poor outcome (p < 0.005) at hospital discharge; generalized slowing was associated with a relatively good outcome (p = 0.003). On multivariate analysis, factors independently predictive of mortality were LVCA, older age, and poor GCS. In conclusion, LVCA and generalized background slowing were common EEG patterns among critically ill intensive care unit (ICU) patients with encephalopathy of varied etiologies. While LVCA was associated with a poor outcome, generalized background slowing predicted better prognosis. Conventional short-duration, bedside EEG studies could aid in the recognition of electrographic patterns of prognostic importance in facilities where continuous EEG monitoring is lacking.
Collapse
|
40
|
Fernández-Torre JL, Kaplan PW, Hernández-Hernández MA. New understanding of nonconvulsive status epilepticus in adults: treatments and challenges. Expert Rev Neurother 2015; 15:1455-73. [DOI: 10.1586/14737175.2015.1115719] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
41
|
Abstract
To determine the optimal use and indications of electroencephalography (EEG) in critical care management of acute brain injury (ABI). An electronic literature search was conducted for articles in English describing electrophysiological monitoring in ABI from January 1990 to August 2013. A total of 165 studies were included. EEG is a useful monitor for seizure and ischemia detection. There is a well-described role for EEG in convulsive status epilepticus and cardiac arrest (CA). Data suggest EEG should be considered in all patients with ABI and unexplained and persistent altered consciousness and in comatose intensive care unit (ICU) patients without an acute primary brain condition who have an unexplained impairment of mental status. There remain uncertainties about certain technical details, e.g., the minimum duration of EEG studies, the montage, and electrodes. Data obtained from both EEG and EP studies may help estimate prognosis in ABI patients, particularly following CA and traumatic brain injury. Data supporting these recommendations is sparse, and high quality studies are needed. EEG is used to monitor and detect seizures and ischemia in ICU patients and indications for EEG are clear for certain disease states, however, uncertainty remains on other applications.
Collapse
|
42
|
van Graan LA, Lemieux L, Chaudhary UJ. Methods and utility of EEG-fMRI in epilepsy. Quant Imaging Med Surg 2015; 5:300-12. [PMID: 25853087 DOI: 10.3978/j.issn.2223-4292.2015.02.04] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2014] [Accepted: 01/22/2015] [Indexed: 12/13/2022]
Abstract
Brain activity data in general and more specifically in epilepsy can be represented as a matrix that includes measures of electrophysiology, anatomy and behaviour. Each of these sub-matrices has a complex interaction depending upon the brain state i.e., rest, cognition, seizures and interictal periods. This interaction presents significant challenges for interpretation but also potential for developing further insights into individual event types. Successful treatments in epilepsy hinge on unravelling these complexities, and also on the sensitivity and specificity of methods that characterize the nature and localization of underlying physiological and pathological networks. Limitations of pharmacological and surgical treatments call for refinement and elaboration of methods to improve our capability to localise the generators of seizure activity and our understanding of the neurobiology of epilepsy. Simultaneous electroencephalography and functional magnetic resonance imaging (EEG-fMRI), by potentially circumventing some of the limitations of EEG in terms of sensitivity, can allow the mapping of haemodynamic networks over the entire brain related to specific spontaneous and triggered epileptic events in humans, and thereby provide new localising information. In this work we review the published literature, and discuss the methods and utility of EEG-fMRI in localising the generators of epileptic activity. We draw on our experience and that of other groups, to summarise the spectrum of information provided by an increasing number of EEG-fMRI case-series, case studies and group studies in patients with epilepsy, for its potential role to elucidate epileptic generators and networks. We conclude that EEG-fMRI provides a multidimensional view that contributes valuable clinical information to localize the epileptic focus with potential important implications for the surgical treatment of some patients with drug-resistant epilepsy, and insights into the resting state and cognitive network dynamics.
Collapse
Affiliation(s)
- Louis André van Graan
- 1 Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK ; 2 MRI Unit, Epilepsy Society, Chalfont St. Peter SL9 0RJ, UK
| | - Louis Lemieux
- 1 Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK ; 2 MRI Unit, Epilepsy Society, Chalfont St. Peter SL9 0RJ, UK
| | - Umair Javaid Chaudhary
- 1 Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology, London, UK ; 2 MRI Unit, Epilepsy Society, Chalfont St. Peter SL9 0RJ, UK
| |
Collapse
|
43
|
Williamson CA, Wahlster S, Shafi MM, Westover MB. Sensitivity of compressed spectral arrays for detecting seizures in acutely ill adults. Neurocrit Care 2015; 20:32-9. [PMID: 24052456 DOI: 10.1007/s12028-013-9912-4] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
BACKGROUND Continuous EEG recordings (cEEGs) are increasingly used in evaluation of acutely ill adults. Pre-screening using compressed data formats, such as compressed spectral array (CSA), may accelerate EEG review. We tested whether screening with CSA can enable detection of seizures and other relevant patterns. METHODS Two individuals reviewed the CSA displays of 113 cEEGs. While blinded to the raw EEG data, they marked each visually homogeneous CSA segment. An independent experienced electroencephalographer reviewed the raw EEG within 60 s on either side of each mark and recorded any seizures (and isolated epileptiform discharges, periodic epileptiform discharges (PEDs), rhythmic delta activity (RDA), and focal or generalized slowing). Seizures were considered to have been detected if the CSA mark was within 60 s of the seizure. The electroencephalographer then determined the total number of seizures (and other critical findings) for each record by exhaustive, page-by-page review of the entire raw EEG. RESULTS Within each of the 39 cEEG recordings containing seizures, one CSA reviewer identified at least one seizure, while the second CSA reviewer identified 38/39 patients with seizures. The overall detection rate was 89.0 % of 1,190 total seizures. When present, an average of 87.9 % of seizures were detected per individual patient. Detection rates for other critical findings were as follows: epileptiform discharges, 94.0 %; PEDs, 100 %; RDA, 97.9 %; focal slowing, 100 %; and generalized slowing, 100 %. CONCLUSIONS CSA-guided review can support sensitive screening of critical pathological information in cEEG recordings. However, some patients with seizures may not be identified.
Collapse
Affiliation(s)
- Craig A Williamson
- Department of Neurosurgery, University of Michigan Hospital, Ann Arbor, MI, USA,
| | | | | | | |
Collapse
|
44
|
André-Obadia N, Parain D, Szurhaj W. Continuous EEG monitoring in adults in the intensive care unit (ICU). Neurophysiol Clin 2015; 45:39-46. [PMID: 25639999 DOI: 10.1016/j.neucli.2014.11.003] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2014] [Accepted: 11/03/2014] [Indexed: 11/26/2022] Open
Abstract
Continuous EEG monitoring in the ICU is different from planned EEG due to the rather urgent nature of the indications, explaining the fact that recording is started in certain cases by the clinical team in charge of the patient's care. Close collaboration between neurophysiology teams and intensive care teams is essential. Continuous EEG monitoring can be facilitated by quantified analysis systems. This kind of analysis is based on certain signal characteristics, such as amplitude or frequency content, but raw EEG data should always be interpreted if possible, since artefacts can sometimes impair quantified EEG analysis. It is preferable to work within a tele-EEG network, so that the neurophysiologist has the possibility to give an interpretation on call. Continuous EEG monitoring is thus useful in the diagnosis of non-convulsive epileptic seizures or purely electrical discharges and in the monitoring of status epilepticus when consciousness disorders persist after initial treatment. A number of other indications are currently under evaluation.
Collapse
Affiliation(s)
- N André-Obadia
- Service de neurophysiologie et d'épileptologie, hôpital Neurologique P.-Wertheimer, hospices civils de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France; Inserm U 1028, NeuroPain team, centre de recherche en neuroscience de Lyon (CRNL), université Lyon 1, 69677 Bron cedex, France.
| | - D Parain
- Service de neurophysiologie clinique, CHU Charles-Nicolle, 76031 Rouen cedex, France
| | - W Szurhaj
- Service de neurophysiologie clinique, hôpital Roger-Salengro, CHRU, 59037 Lille cedex, France; Faculté de médecine Henri-Warembourg, université Lille 2, 59045 Lille cedex, France
| |
Collapse
|
45
|
Halford JJ, Shiau D, Desrochers JA, Kolls BJ, Dean BC, Waters CG, Azar NJ, Haas KF, Kutluay E, Martz GU, Sinha SR, Kern RT, Kelly KM, Sackellares JC, LaRoche SM. Inter-rater agreement on identification of electrographic seizures and periodic discharges in ICU EEG recordings. Clin Neurophysiol 2014; 126:1661-9. [PMID: 25481336 DOI: 10.1016/j.clinph.2014.11.008] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2014] [Revised: 10/15/2014] [Accepted: 11/07/2014] [Indexed: 10/24/2022]
Abstract
OBJECTIVE This study investigated inter-rater agreement (IRA) among EEG experts for the identification of electrographic seizures and periodic discharges (PDs) in continuous ICU EEG recordings. METHODS Eight board-certified EEG experts independently identified seizures and PDs in thirty 1-h EEG segments which were selected from ICU EEG recordings collected from three medical centers. IRA was compared between seizure and PD identifications, as well as among rater groups that have passed an ICU EEG Certification Test, developed by the Critical Care EEG Monitoring Research Consortium (CCEMRC). RESULTS Both kappa and event-based IRA statistics showed higher mean values in identification of seizures compared to PDs (k=0.58 vs. 0.38; p<0.001). The group of rater pairs who had both passed the ICU EEG Certification Test had a significantly higher mean IRA in comparison to rater pairs in which neither had passed the test. CONCLUSIONS IRA among experts is significantly higher for identification of electrographic seizures compared to PDs. Additional instruction, such as the training module and certification test developed by the CCEMRC, could enhance this IRA. SIGNIFICANCE This study demonstrates more disagreement in the labeling of PDs in comparison to seizures. This may be improved by education about standard EEG nomenclature.
Collapse
Affiliation(s)
- J J Halford
- Department of Neurology, Medical University of South Carolina, Charleston, SC, USA.
| | - D Shiau
- Optima Neurosciences Inc., Alachua, FL, USA
| | | | - B J Kolls
- Department of Neurology, Duke University Medical Center, Durham, NC, USA
| | - B C Dean
- School of Computing, Clemson University, Clemson, SC, USA
| | - C G Waters
- School of Computing, Clemson University, Clemson, SC, USA
| | - N J Azar
- Department of Neurology, Vanderbilt University, Nashville, TN, USA
| | - K F Haas
- Department of Neurology, Vanderbilt University, Nashville, TN, USA
| | - E Kutluay
- Department of Neurology, Medical University of South Carolina, Charleston, SC, USA
| | - G U Martz
- Department of Neurology, Medical University of South Carolina, Charleston, SC, USA
| | - S R Sinha
- Department of Neurology, Duke University Medical Center, Durham, NC, USA
| | - R T Kern
- Optima Neurosciences Inc., Alachua, FL, USA
| | - K M Kelly
- Center for Neuroscience Research, Allegheny Singer Research Institute, Allegheny General Hospital, Pittsburgh, PA, USA
| | - J C Sackellares
- Department of Neurology, Malcolm Randal VA Medical Center, Gainesville, FL, USA
| | - S M LaRoche
- Department of Neurology, Emory University Hospital, Atlanta, GA, USA
| |
Collapse
|
46
|
[French guidelines on electroencephalogram]. Neurophysiol Clin 2014; 44:515-612. [PMID: 25435392 DOI: 10.1016/j.neucli.2014.10.001] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2014] [Accepted: 10/07/2014] [Indexed: 12/11/2022] Open
Abstract
Electroencephalography allows the functional analysis of electrical brain cortical activity and is the gold standard for analyzing electrophysiological processes involved in epilepsy but also in several other dysfunctions of the central nervous system. Morphological imaging yields complementary data, yet it cannot replace the essential functional analysis tool that is EEG. Furthermore, EEG has the great advantage of being non-invasive, easy to perform and allows control tests when follow-up is necessary, even at the patient's bedside. Faced with the advances in knowledge, techniques and indications, the Société de Neurophysiologie Clinique de Langue Française (SNCLF) and the Ligue Française Contre l'Épilepsie (LFCE) found it necessary to provide an update on EEG recommendations. This article will review the methodology applied to this work, refine the various topics detailed in the following chapters. It will go over the summary of recommendations for each of these chapters and underline proposals for writing an EEG report. Some questions could not be answered by the review of the literature; in those cases, an expert advice was given by the working and reading groups in addition to the guidelines.
Collapse
|
47
|
Laccheo I, Sonmezturk H, Bhatt AB, Tomycz L, Shi Y, Ringel M, DiCarlo G, Harris D, Barwise J, Abou-Khalil B, Haas KF. Non-convulsive Status Epilepticus and Non-convulsive Seizures in Neurological ICU Patients. Neurocrit Care 2014; 22:202-11. [DOI: 10.1007/s12028-014-0070-0] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
48
|
Kamel H, Betjemann JP, Navi BB, Hegde M, Meisel K, Douglas VC, Josephson SA. Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care 2014; 19:336-41. [PMID: 22820998 DOI: 10.1007/s12028-012-9736-7] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
BACKGROUND To determine the incidence of electrographic seizures during continuous electroencephalography (cEEG) in the medical and surgical ICU. METHODS We retrospectively reviewed the records of all adults who underwent cEEG in our medical and surgical ICU over a 4.5 year period. Patients with acute brain injury were excluded. Our primary outcome was cEEG documentation of an electrographic seizure, defined as a rhythmic discharge or spike and wave pattern demonstrating definite evolution and lasting at least 10 s. To assess inter-rater variability in cEEG interpretation, two electrophysiologists independently reviewed all available cEEGs of subjects with electrographic seizures documented on their clinical cEEG report and those of an equal number of randomly selected subjects from the remaining cohort. RESULTS Kappa analysis showed a value of 0.88, indicating excellent inter-rater agreement. Electrographic seizures were identified in 12 of 105 patients (11 %, 95 % CI 5-18 %). This rate did not change after excluding patients with a history of seizure, remote brain injury, or seizure-like events before cEEG. In an ordinal logistic regression model controlling for age, sex, and SOFA score, electrographic seizures were associated with lower odds of good outcomes on the Glasgow Outcome Scale at discharge (OR 0.3, 95 % CI 0.1-0.8). CONCLUSION In a tertiary care medical and surgical ICU, electrographic seizures were seen on 11 % of cEEGs ordered for the evaluation of encephalopathy, and were associated with worse functional outcomes at discharge. Our findings confirm the results of a prior study suggesting a substantial burden of electrographic seizures in critically ill encephalopathic patients.
Collapse
Affiliation(s)
- Hooman Kamel
- Department of Neurology and Neuroscience, Weill Cornell Medical College, 525 East 68th St, F610, New York, NY, 10065, USA,
| | | | | | | | | | | | | |
Collapse
|
49
|
Boly M, Maganti R. Monitoring epilepsy in the intensive care unit: Current state of facts and potential interest of high density EEG. Brain Inj 2014; 28:1151-5. [DOI: 10.3109/02699052.2014.920525] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
50
|
Chau D, Bensalem-Owen M, Fahy BG. The impact of an interdisciplinary electroencephalogram educational initiative for critical care trainees. J Crit Care 2014; 29:1107-10. [PMID: 25056845 DOI: 10.1016/j.jcrc.2014.06.012] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2014] [Revised: 05/20/2014] [Accepted: 06/17/2014] [Indexed: 11/29/2022]
Abstract
PURPOSE The purpose of this study is to evaluate the effectiveness of an interdisciplinary electroencephalogram (EEG) educational module for critical care training. Electroencephalogram is increasingly used for diagnosis, monitoring, and treatment decisions in critically ill patients with neurologic and nonneurologic disorders. Continuous EEG monitoring has an expanded role in the intensive care unit as an additional evaluation tool for critically ill patients with altered mental status. MATERIALS AND METHODS During a neurosurgical intensive care rotation, pulmonary critical care fellows participated in an EEG curriculum covering didactics, clinical exposure, and EEG interpretations. Using 25-question evaluation tools, including EEG interpretations, participants were assessed before EEG instruction and after curriculum completion. RESULTS Nine fellows completed the pilot study. Evaluation scores increased from 7.56±2.24 to 16.67±2.96 (P<.001). CONCLUSIONS An interdisciplinary approach was effective for increasing EEG knowledge in critical care fellows as measured by the assessment tools. As an added potential benefit, the pulmonary fellows also learned about sleep disorder-related EEG. This model can be replicated in other institutions for trainees of other specialties interested in critical care.
Collapse
Affiliation(s)
- Destiny Chau
- Department of Pediatrics, Division of Pediatric Anesthesiology, The Children's Hospital of the King's Daughters, Eastern Virginia Medical School, Norfolk, VA
| | - Meriem Bensalem-Owen
- Department of Neurology, University of Kentucky College of Medicine, Lexington, KY
| | - Brenda G Fahy
- Department of Anesthesiology, Division of Critical Care Medicine, University of Florida College of Medicine, Gainesville, FL.
| |
Collapse
|